$HUMA Cashflow Statement | Understand Stock

$HUMA

$0.45 +$0.05 (11.41%) Close

$HUMA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net Income Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Stock-based compensation expense
Change in fair value of Contingent Earnout Liability
Non-cash interest expense
Change in fair value of derivatives
Loss on disposal of property and equipment
Loss on extinguishment of debt
Payment of liabilities assumed in Merger
Inventory reserve
Amortization expense
Non-cash operating lease costs
Amortization of SVB debt discount
Accrued interest on PPP loan obligation
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Operating lease obligation
Deferred payroll taxes

Net cash used in operating activities
Cash flows from investing activities
Purchase of property and equipment, net
Proceeds from sale of property and equipment
Purchase of short-term investments (certificates of deposit)
Proceeds from maturity of short-term investments (certificates of deposit)
Net cash used in investing activities

Cash flows from financing activities
Proceeds from the Term Loan Facility
Payments of transaction costs related to the Loan Agreement
Payments of costs related to public offering
Payments on revenue interest liability
Settlement of the Purchase Agreement
Proceeds from the Purchase Agreement, net of issuance costs
Payments of transaction costs related to the Purchase Agreement
Proceeds from the exercise of stock options
Proceeds from the JDRF Agreement
Payments of finance lease principal
Payment of transaction costs related to Merger
Proceeds from SVB loan
Proceeds from PPP loan
Principal payments on SVB loan
Payments for debt prepayment and extinguishment costs
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period
Supplemental disclosure:
Cash paid for interest on SVB loan
Supplemental disclosure of noncash activities:
Operating lease right-of-use assets obtained in exchange for lease obligations
Unpaid transaction costs related to the Loan Agreement
Increase in right-of-use assets and lease liabilities resulting from lease remeasurement
Accrual of transaction costs associated with public offering
Purchase of property and equipment in accounts payable and accrued expenses
Issuance of warrants in conjunction with debt
Unpaid liabilities assumed in connection with Merger
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse capitalization
Initial fair value of contingent derivative liability related to revenue interest liability
Debt discount from embedded contingent derivative liability
Issuance of commitment shares pursuant to the Common Stock Purchase Agreement

Comments